Catherine C. Lee is the Consultant at Metacrine.
As the Consultant of Metacrine, the total compensation of Ms Lee at Metacrine is $383,319. There are 3 executives at Metacrine getting paid more, with Dr. Preston S. Klassen M.D., M.H.S. having the highest compensation of $749,375.
Ms Lee is 47, she's been the Consultant of Metacrine since . There are 5 older and no younger executives at Metacrine. The oldest executive at Metacrine, Inc. is Michael B. York, 56, who is the Chief Bus. Officer.
Catherine's mailing address filed with the SEC is 1751 RIVER RUN, SUITE 400, , FORT WORTH, TX, 76107.
Over the last 4 years, insiders at Metacrine have traded over $5,582,700 worth of Metacrine stock and bought 11,645,167 units worth $119,461,162 . The most active insiders traders include Forest Baskett, Scott D Sandell et Anthony A. Jr. Florence. On average, Metacrine executives and independent directors trade stock every 24 days with the average trade being worth of $237,397. The most recent stock trade was executed by Michael York on 26 January 2023, trading 107,054 units of MTCR stock currently worth $43,892.
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Metacrine executives and other stock owners filed with the SEC include: